SAN CARLOS, Calif.--(BUSINESS WIRE)--Helix, a personal genomics company, today announced that its DNA sequencing laboratory has been accredited by the College of American Pathologists (CAP) for ...

SHANGHAI -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, ...

Illumina, Inc. (NASDAQ:ILMN) today announced that HistoGenetics, the leader in high-resolution sequence-based human leukocyte antigen (HLA) testing services, has selected the MiSeq sequencing system ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China ...

Firm will configure MutliGen tests on transrenal platform. Molecular diagnostics firm TrovaGene is to acquire MultiGen Diagnostics’ CLIA-certified laboratory in return for 750,000 shares of TrovaGene ...

Firm will use facility to commercialize epigenetic diagnostic tests for cancer. MDxHealth’s clinical laboratory facility in Irvine, California, was awarded CLIA certification by the Centers for ...

SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that it has received CLIA Licensure from the State of California that permits ...